This photo provided Oct. 9, 2012, by the Minnesota Department of Health shows shows vials of the injectable steroid product made by New England Compounding Center implicated in a fungal meningitis outbreak that were being shipped to the CDC from Minneapolis. About 17,700 single-dose vials of the steroid sent to 23 states have been recalled. The outbreak involves 10 states, including Minnesota. (AP Photo/Minnesota Department of Health)
NASHVILLE, Tenn. (AP) -- New court filings suggest a Massachusetts pharmacy blamed for a deadly outbreak of fungal meningitis last year may have used patient lists from a Nashville clinic to mislead regulators.
The suggestion is part of a statement by the former Saint Thomas Outpatient Neurosurgical Center medical director in a lawsuit brought by Wayne Reed.
Reed is suing the clinic after his wife died when she was injected with contaminated medicine made by the New England Compounding Center.
The Tennessean reports Dr. John Culclasure says an NECC salesman told him the Massachusetts pharmacy board was insisting on patient names because NECC was legally required to have patient-specific prescriptions.
Clinic officials said it was impossible to know in advance which patients would get the injections. The salesman said NECC just needed names.